| 2022 | | Delayed aortic regurgitation after TEVAR procedure: a case report | 김도정, 이승욱, 임상현, 홍유선 |
| 2019 | | Diabetes and the Risk of Infection: A National Cohort Study | 김대중, 김은진, 최영화, 하경화 |
| 2019 | | Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status | 김대중, 하경화 |
| 2023 | | Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes | 김대중, 하경화 |
| 2020 | | Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis | 김대중, 이기황, 정유리, 하경화 |
| 2023 | | Diet quality partially mediates the association between ultraprocessed food consumption and adiposity indicators | 김대중, 하경화 |
| 2020 | | Effect of Pulmonary Hypertension on Clinical Outcomes in Patients With Rheumatic Mitral Stenosis | 김도정, 박범희 |
| 2021 | | Effect of teneligliptin versus sulfonylurea on major adverse cardiovascular outcomes in people with type 2 diabetes mellitus: A real-world study in Korea | 김대중, 하경화 |
| 2021 | | Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study | 김대중, 이나미, 하경화, 한승진 |
| 2024 | | Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations | 김대중, 하경화 |
| 2021 | | Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19 | 김대중 |
| 2020 | | Effects of cigarette smoking on blood lipids in Korean men: Cardiovascular and Metabolic Diseases Etiology Research Center cohort | 김대중 |
| 2023 | | Effects of Residual Arch Tears on Late Outcomes After Hemiarch Replacement for DeBakey I Dissection | 김도정 |
| 2019 | | Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study | 김대중, 이기황, 정유리, 하경화 |
| 2023 | | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study | 김대중, 하경화 |
| 2022 | | Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2021 | | Erratum: Trends in cardiovascular complications and mortality among patients with diabetes in South Korea | 김대중, 하경화 |
| 2019 | | GLP1 improves palmitateinduced insulin resistance in human skeletal muscle via SIRT1 activity | 강엽, 김대중, 김혜진, 이관우, 전자영, 최성이, 한승진 |
| 2022 | | Healthcare resource utilization in patients treated with empagliflozin in East Asia | 김대중, 하경화 |
| 2022 | | Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2020 | | Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study | 김대중, 김혜진, 문소영, 이관우, 전자영, 한승진 |
| 2023 | | Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients | 김대중, 김혜진, 박범희, 이관우, 전자영, 한승진 |
| 2019 | | Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus | 김대중 |
| 2022 | | Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study | 김대중, 하경화 |
| 2023 | | Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea | 김대중, 하경화 |
| 2021 | | Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study | 김대중, 하경화 |
| 2023 | | Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study | 김대중 |
| 2022 | | Maintaining Physical Activity Is Associated with Reduced Major Adverse Cardiovascular Events in People Newly Diagnosed with Diabetes | 김대중, 하경화 |
| 2020 | | Obesity Fact Sheet in Korea, 2019: Prevalence of Obesity and Abdominal Obesity from 2009 to 2018 and Social Factors | 김대중, 이관우 |
| 2022 | | Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations | 김대중 |
| 2022 | | Prevalence and clinical characteristics of fulminant type 1 diabetes mellitus in Korean adults: A multi-institutional joint research | 김대중, 전자영 |
| 2023 | | Prevalence of aortic aneurysms and dissections in patients with systemic vessel aneurysms and dissections; matched case-control study using a national sample cohort | 김도정, 송지혜, 임용철 |
| 2022 | | Psychometric Properties of the Korean Version of the Perceived Therapeutic Efficacy Scale for Physical Activity in Adults With Type 2 Diabetes | 김대중, 김춘자 |
| 2022 | | Recommendation on an updated standardization of serum magnesium reference ranges | 김대중 |
| 2022 | | Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model | 김대중, 박래웅 |
| 2022 | | Reply to “Recommendation on an updated standardization of serum magnesium reference ranges,” Jeroen H.F. de Baaij et al. | 김대중 |
| 2019 | | Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640-8) | 김대중, 이기황, 정유리, 하경화 |
| 2022 | | Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study | 김대중, 하경화 |
| 2020 | | Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study | 김대중 |
| 2022 | | Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022 | 김대중 |
| 2022 | | Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study | 김대중, 김은진, 정윤정, 최영화, 하경화, 허중연 |
| 2022 | | Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: A national observational cohort study | 김대중, 최용준, 하경화 |
| 2021 | | Status of diabetic neuropathy in Korea: A national health insurance service-national sample cohort analysis (2006 to 2015) | 김대중 |
| 2021 | | Status of diabetic neuropathy in Korea: A national health insurance service-national sample cohort analysis (2006 to 2015) (Diabetes Metab J 2021;45:115-9) | 김대중 |
| 2022 | | The Degree of Glycemic Control for the First Three Months Determines the Next Seven Years | 김대중, 이나미 |
| 2020 | | The fate of residual aortic regurgitation after ascending aorta replacement in type A aortic dissection | 김도정 |
| 2019 | | The Need to Improve the Quality of Diabetes Care in Korea | 김대중, 한승진 |
| 2022 | | The Positive Association between Muscle Mass and Bone Status Is Conserved in Men with Diabetes: A Retrospective Cross-Sectional and Longitudinal Study | 김대중, 김혜진, 정윤석, 최용준, 한승진 |
| 2020 | | Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study | 김대중 |
| 2022 | | Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018 (Diabetes Metab J 2021;45:880-9) | 김대중 |
| 2022 | | Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data | 김대중, 하경화 |
| 2021 | | Trends in cardiovascular complications and mortality among patients with diabetes in South Korea | 김대중, 하경화 |
| 2021 | | Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings | 김대중, 하경화 |
| 2020 | | Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea | 김대중, 박인휘, 이민정, 하경화 |
| 2023 | | Ultra-Processed Food Consumption and Obesity in Korean Adults | 김대중, 하경화 |
| 2021 | | Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2019 | | Visfatin Induces Inflammation and Insulin Resistance via the NF-kappaB and STAT3 Signaling Pathways in Hepatocytes | 강엽, 김대중, 김혜진, 이관우, 전자영, 최성이, 한승진 |
